Fate Therapeutics
FATE
FATE
90 hedge funds and large institutions have $385M invested in Fate Therapeutics in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
67% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 21
15% more funds holding
Funds holding: 78 → 90 (+12)
5.95% more ownership
Funds ownership: 68.75% → 74.69% (+5.9%)
Holders
90
Holding in Top 10
2
Calls
$1.26M
Puts
$594K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$11.6M | |
| 3 | +$8.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.27M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.89M |
Top Sellers
| 1 | -$3.92M | |
| 2 | -$2.85M | |
| 3 | -$2.18M | |
| 4 |
Millennium Management
New York
|
-$2.07M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.83M |